Ozempic and Wegovy Have Lower Suicide Risk, Major Study Finds
Listen now
Description
A major new study finds popular diabetes and weight loss drugs Ozempic and Wegovy, which contain the ingredient semaglutide, actually carry a lower risk of suicidal thoughts compared to other medications used to treat obesity and type 2 diabetes. However, the FDA is still investigating potential mental health side effects, so more long-term data is needed.
More Episodes
Originally developed for managing type 2 diabetes, Ozempic has emerged as a popular choice for weight loss, particularly because of its effective reduction in appetite and calorie intake. Ozempic, a brand name of the medication semaglutide, is administered through weekly injections and functions...
Published 05/25/24
Published 05/25/24
Ozempic, originally developed for treating type 2 diabetes, has gained global attention for its effectiveness in promoting weight loss. The medication, which has yet to be officially registered for this specific use in many regions, is seeing off-label use around the world, including in Guyana,...
Published 05/22/24
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
